Cargando…
Identification of cerebrospinal fluid metabolites as biomarkers for neurobrucellosis by liquid chromatography-mass spectrometry approach
Neurobrucellosis is the most morbid form in brucellosis disease. Metabolomics is an emerging method which intends to explore the global alterations of various metabolites in samples. We aimed to identify metabolites in cerebrospinal fluid (CSF) as biomarkers that were potentially unique for neurobru...
Autores principales: | Yang, Hao, Wang, Zhenfei, Shi, Shujun, Yu, Qin, Liu, Meiling, Zhang, Zhelin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974019/ https://www.ncbi.nlm.nih.gov/pubmed/35249459 http://dx.doi.org/10.1080/21655979.2022.2037954 |
Ejemplares similares
-
Treatment Efficacy and Risk Factors of Neurobrucellosis
por: Zhao, Shigang, et al.
Publicado: (2016) -
A Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneously Determining Meropenem and Linezolid in Blood and Cerebrospinal Fluid
por: Berska, Joanna, et al.
Publicado: (2024) -
Ensuring Fact-Based
Metabolite Identification in Liquid
Chromatography–Mass Spectrometry-Based Metabolomics
por: Theodoridis, Georgios, et al.
Publicado: (2023) -
Identification of New Metabolites of Bacterial Transformation of Indole by Gas Chromatography-Mass Spectrometry and High Performance Liquid Chromatography
por: Arora, Pankaj Kumar, et al.
Publicado: (2014) -
Quantification of 4-Methylimidazol in NMRI Mice Plasma and Cerebrospinal Fluid (CSF) by Using Liquid Chromatography Tandem Mass Spectrometry
por: Mehri, Fereshteh, et al.
Publicado: (2020)